These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7160291)

  • 21. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability of the activated coagulation time.
    Gravlee GP; Case LD; Angert KC; Rogers AT; Miller GS
    Anesth Analg; 1988 May; 67(5):469-72. PubMed ID: 3364767
    [No Abstract]   [Full Text] [Related]  

  • 23. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
    Watanabe T; Abe T; Iyomasa Y
    Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heparin management by activated coagulation time during cardiopulmonary bypass].
    Shikano K; Shinpo H; Nasu M; Morimoto T; Suzuki T; Yada I; Kusagawa M
    Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.
    Fromes Y; Daghildjian K; Caumartin L; Fischer M; Rouquette I; Deleuze P; Bical OM
    Anaesthesia; 2011 Jun; 66(6):488-92. PubMed ID: 21501130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients].
    Jiang L; Yu JF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protamine titration after cardiopulmonary bypass.
    Dutton DA; Hothersall AP; McLaren AD; Taylor KM; Turner MA
    Anaesthesia; 1983 Mar; 38(3):264-8. PubMed ID: 6837905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reevaluation of heparin requirements for cardiopulmonary bypass.
    Cardoso PF; Yamazaki F; Keshavjee S; Schaefers HJ; Hsieh CM; Wang LS; Glynn MF; Patterson GA; Cooper JD
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):153-60. PubMed ID: 1986159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin resistance after intraoperative platelet-rich plasma harvesting.
    Wickey GS; Keifer JC; Larach DR; Diaz MR; Williams DR
    J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1172-6. PubMed ID: 1597982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-assisted heparin monitoring.
    Coe JM; Soloway HB
    Am J Clin Pathol; 1979 Jul; 72(1):74-6. PubMed ID: 453115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald D
    Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
    [No Abstract]   [Full Text] [Related]  

  • 33. [A computerized method for the administration of heparin and protamine during open-heart surgery].
    Isshiki A; Sakaguchi Y; Kubota K; Ikeda T
    Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses.
    Umlas J; Taff RH; Gauvin G; Swierk P
    Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activated clotting time loading dose response ratio (ACTLORR) as an indicator of heparin demand during cardiopulmonary bypass.
    Reece IJ; Linley G; al Tareif H; DeVroege R; Tolia J; Sheth J
    Perfusion; 1996 Mar; 11(2):125-30. PubMed ID: 8740353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
    Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin rebound: a comparative study of protamine sulfate and protamine chloride in CABG surgery.
    Kuitunen A; Salmenperä M; Heinonen J; Rasi V; Myllylä G
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):81. PubMed ID: 2521014
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of activated clotting time to monitor anticoagulation during cardiac surgery.
    Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV
    Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ; Alsoufiev AL; Spitznagel E; Goodnough LT; Lappas DG
    Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.